# Lenalidomide in combination with rituximab for patients with relapsed or refractory mantle-cell lymphoma: a phase 1/2 clinical trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/lenalidomide-in-combination-with-rituximab-for-patients-with-relapsed-or/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Michael Wang,Luis Fayad,Nicolaus A. Wagner‐Bartak,Liang Zhang,Fredrick Hagemeister,Sattva S. Neelapu,Felipe Samaniego,Peter McLaughlin,Michelle A. Fanale,Anas Younes,Fernando Cabanillas,Nathan Fowler,Kate J. Newberry,Luhong Sun,Ken H. Young,Richard E. Champlin,Larry W. Kwak,Lei Feng,Maria Badillo,Maria Teresa Bejarano,Kimberly Hartig,Wendy Chen,Yi‐Ming Chen,Catriona Byrne,Neda Bell,Jerome B. Zeldis,Jorge Romaguera |
| Citations | 297 |
| DOI | 10.1016/s1470-2045(12)70200-0 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2098002594 |
| PMID | 22677155 |
| Type | article |
| Year | 2012 |

## Paper authors

- [Yi‐Ming Chen](https://scholariq.org/researchers/yi-ming-chen/)

## Paper journal

- [The Lancet Oncology](https://scholariq.org/journals/the-lancet-oncology/)

## Paper primary topic

- [Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/lymphoma-diagnosis-and-treatment/)

## Paper topics

- [Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/lymphoma-diagnosis-and-treatment/)
- [Multiple Myeloma Research and Treatments](https://scholariq.org/topics/multiple-myeloma-research-and-treatments/)
- [Cutaneous lymphoproliferative disorders research](https://scholariq.org/topics/cutaneous-lymphoproliferative-disorders-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.